.4baseCare, a precision oncology company focused on building population-relevant clinico-genomic intelligence, has raised an additional Rs 38 crore led by growX ventures and existing investors, as part of its extended Series B funding round. This top-up round has brought 4baseCare’s total Series B raise to Rs 128 crore, says a company statement. Earlier this year, the company had announced a raise of Rs 90 crore in its Series B round, co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing backer Yali Capital. The company is expanding its hospital-linked genomics laboratory network across India, southeast Asia, Latin America, and central Asia, to improve access to advanced genomic testing and precision cancer care.
Med startup raises Rs 38cr
4baseCare, a precision oncology company focused on building population-relevant clinico-genomic intelligence, has raised an additional Rs 38 crore led by growX ventures and existing investors, as part of its extended Series B funding round. This top-up round has brought 4baseCare’s total Series B raise to Rs 128 crore, says a company statement.
TL;DRAI
4baseCare closed Rs 38cr Series B top-up (total Rs 128cr), scaling genomics labs across India, SE Asia, Latin America, and Central Asia. For healthcare tech leaders, this signals genomic intelligence becoming critical infrastructure for precision oncology in emerging markets.
113 words~1 min read
